Active substance |
Nusinersen |
Holder |
Clinigen Group plc |
Status |
Closed |
Indication |
Infantile-onset (Type I) Spinal Muscular Atrophy (SMA) |
Public documents |
|
Last update |
31/08/2018 |
Spinraza®
Last updated on 13/09/2024